APTA — Aptamer Share News
0.000.00%
Last trade - 00:00- £9.88m
- £5.70m
- £1.54m
AIM - AIM Notice - 28/07/2025
AIM - AIM Notice - 24/07/2025
Additional work commissioned by Unilever
Issue of Equity in lieu of Non-Exec Director Fees
Holding(s) in Company
AIM - AIM Notice - 09/07/2025
Posting of Circular and Notice of General Meeting
Brief: Aptamer Group Announces Placing To Raise £2.0 Mln
Placing to raise £2.0 million
Liver fibrosis breakthrough with Optimer® platform
Agreement with global life sciences leader
Unilever second Optimer development programme
Aptamer Announces New Data at ASGCT
Optimer licensing agreements and repeat contracts
Brief: Aptamer Finalises Royalty Agreement With Neuro-Bio
Alzheimer’s test advanced and royalty agreement
Brief: Aptamer Group Says Licensing Agreed For Optimer As Vaccine Adjuvant
Licensing agreed for Optimer as vaccine adjuvant
Aptamer Presenting at ASGCT Annual Meeting